Looking to buy your dream home or rent that perfect apartment? With the Redfin app, you'll know the moment your next place hits the market. Set up your gotta-have-it wishlist, and Redfin will send you real-time notifications for properties that match. And when you're ready to see it in person, scheduling a tour is just a tap away.
Thinking about selling? Redfin can do that too. In fact, Redfin agents close twice as many deals as other agents, so they know how to get the best price for your home. And with a listing fee as low as 1%, Redfin charges half of what others often charge. So you can save big, like really big.
Last year, Redfin saved home sellers $118 million. So whether you're buying, renting, or selling, Redfin's ready to help you win. Download the Redfin app and start searching today.
Are you still quoting 30-year-old movies? Have you said cool beans in the past 90 days? Do you think Discover isn't widely accepted? If this sounds like you, you're stuck in the past. Discover is accepted at 99% of places that take credit cards nationwide. And every time you make a purchase with your card, you automatically earn cash back. Welcome to the now. It pays to discover. Learn more at discover.com slash credit card based on the February 2024 Nelson report.
Bring in show music, please. Hi, I'm CNBC producer Katie Kramer. Today on Squawk Pod. Your spit's journey from DNA database to the drug pipeline? The story of what happens to bankrupt consumer DNA brand 23andMe. Regeneron CEO Len Schleifer tells us what he has planned should he win the bid.
Our genetics predicts all the half a dozen or more indications that Tupixin would work and to treat allergic diseases. And U.S. and China officials agree, in theory, to a trade deal in the making. And this is basically a framework.
Plus, Elon Musk apologizes after railing against President Trump on X and a tough vibe for the Margaritaville estate. Robert Frank reports on Jimmy Buffett's financial legacy and the millions caught in a legal battle.
The irony here is he had a very detailed, well-constructed plan for this estate. And it still fell apart because of often the reason they fell apart, which is personalities. It's Wednesday, June 11th, 2025. Squawk Pod begins right now. Stand back here by in three, two, one. Cue, please.
Good morning, everybody. Welcome to Squawk Box right here on CNBC. We're live from the Nasdaq market site in Times Square. I'm Becky Quick along with Joe Kernan. Andrew is off today. Yesterday, you saw the markets up across the board. The Nasdaq has actually been up for now six sessions in a row. And you're talking about getting so much closer to those highs that had been set back in February.
At this point, the Dow is down by less than 2% from those highs. The Nasdaq not far from it either. And even the Dow is less than about 5% from the highs. So I think both sides had extra impetus in order to get things done because we both have our presidents behind us pushing us to make sure we take care of our respective sides.
The U.S. and China signaling success at this point after two days of high-level trade talks in London. Officials from both countries said they agreed on a framework to get a truce reached, what we saw last month come out of Geneva, to get that back on track.
Commerce Secretary Letnick telling reporters that the deal would remove restrictions on some Chinese exports of rare earth minerals, as well as some recent U.S. export restrictions on some high tech stuff. But we haven't heard further details yet. The deal will await final approval from President Trump and President Xi.
of China, when he was announcing it yesterday, he was, you know, as he does, he was very optimistic about it. But the Chinese people that were there were nodding and saying, yes, that's true. Yes, that's true. It is pointed out by some in, you know, different newspapers that the lack of clarity indicates and actually Blutnick said that
The president or we will remove sort of certain restrictions on export. So it's some people are surmising that the president needs to.
instruct his negotiators exactly which exports he's willing to remove restrictions on. But it looks like it's going to get done. But then there's a lot of hard work that still needs to be done. This gets us to the position, this is basically a framework to say we will then look at trying to fix some of these trade issues. I mean, it does underscore the difficulty of when you combine these national security issues with the trade talks on some of these things, too.
Because if you believe the rhetoric from what we've been listening to in the last several months and even the last several years from multiple administrations, the idea that you cannot export some of these semiconductors and other things because it would be seen as a threat to national security. All of a sudden, we're going to say, OK, that's not the case in some of these issues. For now, we we are not going to decouple from China in terms of trade. You can't do our economies. But I can't say that will always be the case, given China.
than what happens in the next decade. I have, you know, depends on whether you're a real hawk on China or more of a dove. I mean, it'd be good to be optimistic and half full and say, look, they need us. We need them. Right. Eventually, maybe.
you know we've been hoping for so long that that things would change about their whole system uh and it never has and everybody's got the internet over there everybody's got social media they know not the same not the same yeah probably not the same what's a tnm but um
And look at this. There are all kinds of frustrations from allowing China into the WTO back in 2000 or whenever that happened of them not playing by the rules and it not being enforced properly. Those are the frustrations that have been borne out over decades. And hawks would point to much worse things than just that. The theft of intellectual property, spying, buying a farmland near.
I don't know what the... I mean, there's even a huge debate that was played out in the Sunday newspapers in London about the idea of them being able to build a huge new embassy that's very closely and goes over some of the areas where the cables are laid for financial firms in that same area. And hacking, we know a lot of... They're still coming from there and not... There's a lot of things that...
China probably pointed what's going on in L.A. and said, we got the Uyghurs, but you do that. It's not comparable. It's not the same, at least in my view. But the markets, you might ask, wow, China trade deal, what's going on? Well, this gets us back again to where we were a month ago. It's all in the news. And we don't know details either. Right. And that's part of the big issue on this. Now, some of the Asian technology companies have traded higher on this. I think the potential for the relief on the...
exports has seen as something that's new, but you're right, we don't have the details and we'll have to wait. S&P is up for the year now, right? Yeah. Is it up for the year? Up for the year. It's up 20% or so. Oh, from the start of the year, yeah. But we had those highs back in February that were still reaching back. Yeah, we did. NASDAQ is up another 130 points or so. Right, yeah. Significant moves. Elon Musk, uh...
He's sorry. This is the closest I've ever seen to a public apology. You'd have to, you know,
At some point. And I've tweeted things, I guess. I mean, I think long and hard. I don't really tweet much. But I've, you know, not at midnight. Not good. No, not if there's any type of mental. Yeah. Or anything involved. Not a good idea at that point. But expressing some regret over his public feud with President Trump in a post on X earlier this morning. Musk said, I regret some of my posts about President Trump.
At real Donald Trump Bob last week they went too far musk has removed some of the most inflammatory things he posted about the president including
An agreement with someone who said Trump should be impeached and also saying the president's name appeared in the files about the late sex offender Jeffrey Epstein. Musk is gearing up for the launch of Tesla's robo taxi service in Texas. Don't forget. And last night he posted that rides were tentatively scheduled to begin on June 22nd.
The President posts late at night sometimes. And there's some saucy... But he doesn't drink. That's what I was going to say. There's some saucy language at times. Just know that what you see, that's the President sober. So let's just be... I think it's...
I don't even know how, what that would be. Look, I have heard from people in the Elon Musk sphere who had been hoping for an apology. I think they're afraid to ask him for an apology because when you ask him to do something, he's very likely not to do it. I think this is the closest I've ever seen to a public apology that comes into. Well, what, if you were...
the 10th richest person in the world, would you apologize to anything? Me? No. Neither would I. If I was the richest, if I had like...
I don't think, you know, I need how many, what is it, 8, 10, how many figures is that? Was it 100 billion or 200 billion? I don't even know. But if you had that, I don't. I just go back to that Geiger capital thing, you know, the differences in seconds versus, there were a million seconds. There are a trillion is back then. I don't know how much. I wouldn't be groveling too much very often. But there's only one person that you probably ought to grovel to.
a leader of the free world. That's why this was so interesting. It got so much attention from so many people. ♪
Los Angeles police making arrests after they began to enforce a new curfew for the city's downtown. Officials said that the curfew was necessary to prevent vandalism and theft by people looking to cause trouble in the midst of protests over the Trump administration's immigration crackdown. Los Angeles Mayor Karen Bass said that the area where people would be subject to arrest is a small fraction of the nearly 500 square miles that make up the city.
Meantime, in an address last night, California Governor Gavin Newsom sharply criticized the White House's tactics. California may be first, but it clearly will not end here. Other states are next. Democracy is next. Democracy is under assault before our eyes. This moment we have feared has arrived.
Newsom has asked a court to put an emergency stop to the military helping federal immigration agents. A judge set a hearing on that for tomorrow. Meantime, sources familiar with the planning of future operations tells NBC News that Immigration and Customs Enforcement is preparing to deploy its special response teams to five cities run by Democratic leaders. When you're in a hole, what's that expression? Stop digging? Yeah. Keep working it. Double down. That's going to work. Democracy's at risk.
You know, I did see one great quote yesterday from one of the anchors out there. I don't think it was a national anchor, but he goes, he said that the vast majority is peaceful except... So there are a few people that are having fun burning some cars, watching some cars burn. That's as bad as... He literally used the term that, okay, some people are having some fun watching some cars burn. There have been businesses that have been looted. There have been fires downtown. We've seen it. It's... I can...
Coming up, Regeneron's $256 million bid for the bankrupt DNA testing site 23andMe. What CEO, Dr. Len Schleifer, is planning if he wins all that genetic data?
What you need to do is get DNA and get health information, marry them, but strip out any personal identifier. Once you have that, we have shown that the more people you have, the more power you can ask questions about how our genes determine our health. Squawk Pod will be right back with that exclusive interview. And you should stick around. If you ever spat in a tube to find out what percentage Southern Italian you are, this guy may one day have your DNA.
This episode is brought to you by Square. Your favorite neighborhood spots run on Square. Did you know Square can help you turn your small business idea into a huge success? Even that genius idea for moving with monkeys. The pop-up workout class taught by, yes, real monkeys.
Square isn't just a point of sale for local businesses anymore. What began as a little white card reader is now a behind-the-scenes powerhouse, helping you manage finances, schedule your team, and cover cash flow gaps when they come up. With Square, you could keep things at moving with monkeys running smoothly, even if one of your instructors won't stop flinging bananas at the clients. And whether you're expanding to new cities or growing your loyal following of primate-loving fitness buffs, Square is with you every step of the way.
Amazon has everything for every kind of Father's Day. Whether that's a waffle maker for his beloved breakfast in bed. Come to Papa.
Or new pickleball paddles for some friendly father-son competition. Or gifts like a steel shaker for his signature dad hat and cocktail. From cookware to sports gear, shop everything for Father's Day on Amazon.
This episode is brought to you by Schwab Market Update, an original podcast from Charles Schwab. Join host Keith Lansford for this information-packed daily market preview delivered in 10 minutes or less, including projected stock updates, monetary policy decisions, and key results and statistics that may impact your trading. Download the latest episode and subscribe at schwab.com slash market update podcast or find Schwab Market Update wherever you get your podcasts.
Welcome back. You're listening to Squawk Pod from CNBC. Here's Becky Quick. Welcome back, everybody. The sale of bankrupt genetic testing company 23andMe has come under scrutiny for privacy and national security concerns. Congressman James Comer of Kentucky joined us yesterday ahead of his House Oversight Committee hearing and had this to say about the potential buyer of 23andMe.
Regeneron has very close ties to the Chinese Communist Party. We're very concerned about that. We're not accusing anyone of any wrongdoing, but we know that they've had deals before in the past that were partially funded by Chinese Communist Party linked entities. So that's a concern.
All right, joining us right now is Regeneron's founder, chairman and CEO, Dr. Len Schleifer. Regeneron announced a $256 million deal to acquire 23andMe back in May, but 23andMe wants to reopen the bidding after receiving a $305 million offer from its co-founder and former CEO, Ann Wojcicki. All right.
Len, first of all, thank you for joining us. I was surprised to hear this coming out of the congressman's mouth yesterday and kind of push back immediately. Like, wait a second, Regeneron, we know Lynch Leifer. He comes in here ties close ties to the Communist Party. Joe and I were both like, what?
- Let's just get to, do you speak Mandarin, Leifer? - Not a word. - Not fluent? - Not one word. - Have you been to China? - I've never been to China. - You called immediately and said, what is he talking about? - Yeah. - What is he talking about? - Well, I think the honorable Congressman from Kentucky
uh... and chair of the house oversight committee is trying to do his job in protect uh... american individuals data from falling in to the wrong hands but as far as him saying that we have very close ties with the communist chinese government uh... that's just categorically not true i suspect he might be given some wrong information by staff what what deals have you done with china that they could be construed into that yet so uh...
Our main products are actually sold through non-Chinese companies who have businesses in China, like Sanofi sells our Dupix in China, Bayer sells our Aili in China. So we don't actually have any direct business in China. We have done some licensing deals and some supplies agreements, things like that, like every other company does, but nothing that you
would consider... You offered a therapeutic for a virus that originated in a lab in China. And we did come up with... That doesn't really constitute close... Maybe that is close ties to the CCP. I don't know whether the CCP was... They create the disease and we create the cure. Yeah, exactly. So you do have ties. I don't think it exactly works that way. No, it's not... And, you know, as you know well, that monoclonal antibody saved the president Trump's life. So...
It was a timely therapeutic. It was. That's a whole other story. We could devote hours to it. Well, let's talk about 23andMe. I am somebody who has given my genetic material to 23andMe a long time ago, 14, 15 years ago. I have concerns about what this means. Why do you want it? Right. So look,
We understand privacy concerns and individuals not wanting their DNA to fall into other people's hands for nefarious reasons or for no reason. You're entitled to manage your own DNA. On the other hand, I have a child with a genetic illness, and I would be happy if his genetics would be able to help other children like him or prevent disease in the future. And so there is this tension between
doing world-class research with genetics which regeneron does we have sequenced nearly three million individuals in a totally de-identified way and so we're trying to balance absolutely respecting individuals privacy but moving forward in biotechnology and genetics research
As the consumer, I mean, look, I have a child with a rare genetic disease, too, and I'm all in favor of that. But as a consumer, I didn't give you the right to have my genetic material. Should there be an opt-in policy instead of an opt-out policy as it exists today? How do I know that you're going to protect...
my safety and my standards and my privacy. -Yeah, you know, the details of the consent forms and what have you is something that the court is looking over very carefully. As far as if we were the winner, I think we have a long history of protecting people's genetic and other health information, and we take that extremely seriously.
But once again, we're trying to set this balance. You know, there's a commission called the National Security Commission on Emerging Biotechnology. And actually, Eric Schmidt is one of the, of Google fame, is one of the commissioners.
They recognize that we're in a big competitive situation here. And biotechnology is critical to our national security, literally our physical security, our health security, our food security. And we have to make sure that we advance that in a way that's consistent with Americans' belief that individuals have the right to-- - But why is it for sale? Why is my information for sale?
Instead of me saying, okay, I agree with you and I'll sign off and you can take it. Yeah, I'm perfectly happy with people affirmatively signing off or not signing off is the case. Because I'd have different thoughts if it was a Chinese company. I wouldn't want them to. I don't understand why Regeneron's even interested except that it's 200... What is that? You find that in the couch? You're a $55 billion company. That was a company that was worth a lot more. Is this just a...
an attractive price. Does it fit in with Regeneron's long-term business? We don't know if we're even going to win this. No, but if you did, I don't see it as some type of... Is it essential to us? Absolutely not. Does it do anything for you other than it's really cheap? No, well, we just don't want to buy things that are cheap, you know. We want to buy things that have value to us. Well, I mean, it's sort of you could...
It might take a lot of dots to get to how it makes sense for Regeneron, right? No, I think that, remember, we have done more to use genetics to create new drugs, I think, than any other company in our industry. And we could do with more genetics, we could get more drugs faster. And so I think that is important. How would it work? Like, if you had this information, how would you kind of put it into your pipeline? What would you be going after first? Do you already have targets for Regeneron?
drug potential candidates are yet what what the genetics actually would allow you to do once we over satisfied properly the privacy aspects uh... of
acquiring the DNA and de-identifying it so it can be utilized without knowing whose it is. What you need to do is get DNA and get health information, marry them, but strip out any personal identifier. Once you have that, we have shown that the more people you have, the more power you can ask questions about how our genes determine our health.
And if you can figure that out, you can come up with drugs, as we have. Some of the biggest and most important drugs in the world have been predicted exactly like Dupixent are genetics.
predicts all the half a dozen or more indications that Tupixin would work and to treat allergic diseases. Like what? For allergic diseases? Yeah, allergic diseases like asthma, like eczema, like eosinophilic esophagitis and so forth. Chronic obstructive pulmonary disease. The genetics provide you a lot of confidence on how to proceed, where to proceed. You're swaying me. Okay. You are swaying me because I do know one of the huge arguments in the rare genetic disease community is
If we could test children as they're born, babies as they're born, that would be the key to trying to find cures, trying to find better identification and better treatment. Let me give you a fabulous example that will really get you on our side. If you imagine there are children, not that many, who are born profoundly deaf.
And we now know it's because of a single gene mutation that they're profoundly deaf. Well, the scientists at Regeneron have actually -- and we can show you -- maybe the next time we're here, we can show you a video of a child who never heard anything, and now it can communicate, talk,
and understand because we put a gene back in their ear, back in their ear, and it restored hearing. That is a miracle. How does it go back into the genome, not just the ear? Yeah, you have to inject it. Do you get it to go, is it expressed in the kid's genome from there on out? No, no, no, it's just expressed in the inner ear. The single base pair or a stretch? No, we put in a whole gene. Yeah, a stretch.
It's unbelievable that you can do this and you can make... Where is it? How does it go? Where's the gene? We make the gene. And put it into what to go into the ear? Well, we put it into an AAV. A little plasmid. To an AAV, a virus that carries it. So it's an actual genetic editing. Yes. It's in a virus? It's not in a virus. Well, AAV. No, no associated virus. And you put it in and it's remarkable how you can...
Give a child the gift of hearing. I mean, you know, it's emotional just to think about it. And if that could be done for your child or my child, more complicated perhaps, or other children. You've swayed me. You've swayed me, and I go along with that. I do think you have to follow a very high standard. I trust you.
to do that. But there is a higher offer that's potentially out there for Ann Wojcicki. Would you raise your bid? She's offering $305 million. Would you raise your bid for this? Is it worth more? We'll get a chance to see that when the auction reopens. Can't talk about our strategy on that. Well, I think you can go up from there, Len. We'll see. Forgetting about the details of 23andMe, whether or not we get it or not, we're going to be in the genetics business. We're going to use genetics in a
compliant way but we're gonna use it to advance health security and we've got to have a bigger conversation you guys can lead it we have got to stop attacking the pharmaceutical industry the biotechnology industry we've got to do something that at the same time satisfies affordability which is really important right but also we're gonna lose the race remember a long time ago
The United States made like 40% of the chips. Now, you know, it dropped down to like 5 or 10%. We're the leaders in biotechnology.
But the Chinese and others are investing heavily, and they're catching up or going to pass us. And if we keep attacking this industry instead of congratulating it and working with it and monitoring it, it's okay. It's okay that they held a hearing, that Comer and Lynch held a hearing to make sure people's private genetic information remains private. But we've got to force this industry to move forward, or we are in deep trouble. Yeah, I...
I think you made a very cogent argument and one that definitely sways me. I would like to see more of what you guys are working on with this. Comer probably did mean 23andMe, I think. You could ask him that, but it couldn't be Regeneron. Exactly. And you don't want China getting 23andMe. I don't want China to have this information. We don't either.
So we just won't shake hands because I'll get your DNA when I leave. No, the things you guys are working on when it comes to this, I think, are amazing. And you're right. And there needs to be oversight of it. But can I ask you something out of left because I keep seeing it on Twitter. Do you think that that mRNA vaccines, that that proteins are made?
years after by the mRNA that was injected for the vaccine. I don't believe that. Isn't the half-life of messenger RNA like... It's short. I doubt that. I'm not the world's expert. Is there any way it could be reverse transcribed into someone's genome? No.
You know what I mean? Like an RNA virus. I would doubt it. But I think that, you know, look, it's like anything else. It's not yes or no. There are issues with vaccines that if you don't design them right or you overstimulate the immune system, that can be a problem. Or if you take too many. We don't know the effect of the immune system. You've got to study them. On the other hand...
Yeah, they saved our bacon. Dying is not such a great alternative. No. So polio. There's a lot of diseases. Look, I remember taking the polio vaccine in school. I mean, as a school kid. That's the thing. We have forgotten how fortunate we are to have made this progress. It's okay to have a conversation. Len, they're taking us away. Please come back. We're going to continue this conversation. Absolutely. Great to see both of you. Thanks, Dr. Schlepper.
Up next on Squawk Pod, island attitude turned hostile. Robert Frank reports on the battle for Jimmy Buffett's Margaritaville. There's $85 million at stake, plus a little extra. $35 million in real estate, $15 million in private jet and airplane holdings, $11 million in fine art, $5 million in cars, so Jimmy liked his cars, and $2 million in musical instruments. The
The empire of the Parrotheads, right after this.
This episode is brought to you by Schwab Market Update, an original podcast from Charles Schwab. Join host Keith Lansford for this information-packed daily market preview delivered in 10 minutes or less, including projected stock updates, monetary policy decisions, and key results and statistics that may impact your trading. Download the latest episode and subscribe at schwab.com slash market update podcast or find Schwab Market Update wherever you get your podcasts.
This is SquawkPod.
Stand by Joe in three, two, his mic, cue. You're watching Squawk Box on CNBC. I'm Joe Kernan, along with Becky Quick. Andrew is off today. Some negative vibes. There should never be any negative vibes hanging over Margaritaville. That's the whole point.
a battle is intensifying over the late jimmy buffett's estate and cnbc's uh wealth reporter robert frank joins us now with more i would just say i mean margaritas are the greatest drink of the most popular drink were they popular as popular before or did
That's going to actually make it even more popular. I think a little bit of both. He certainly did a great job commercializing the margarita through Margaritaville and everything else. And that is now the subject of this big battle because Jimmy Buffett's widow battling his longtime accountant over a trust.
estimated at over 275 million dollars. Now Jane Buffett who married Jimmy back in 1977 is seeking to remove Rick Mosenter as her co-trustee of the marital trust. Now when Jimmy Buffett died two years ago most of his assets went into the trust. Those assets include 85 million dollars in equity in the aforementioned Margaritaville, that's the Buffett themed company that has 30 restaurants and bars, 20 hotels,
along with retirements, cruises, lots of communities there. $35 million in real estate, $15 million in private jet and airplane holdings, $11 million in fine art, $5 million in cars, so Jimmy liked his cars, and $2 million in musical instruments. Supposed to have a lot of guitars. Now, Jane Buffett says Mozenter has refused to give her financial details.
and has been, quote, openly hostile and adversarial. She says the $2 million a year in projected income from the trust marks a return of less than 1%. Now, Mozento, for his part, he's filed his own lawsuit seeking to remove Jane, saying she has been, quote, completely uncooperative and needs to adjust her lifestyle to live on the mere $2 million a year. Now, a judge is ultimately going to decide whether either it was going to stay or be replaced by her for
professional trustee or maybe he'll just decide they need changes in attitudes so to speak now for more on the buffett case and lessons for other families that are passing down wealth from this case check out the inside wealth newsletter at cnbc.com inside wealth that's cnbc.com inside wealth i'm really sad to hear this um nobody wants to hear about squabbles especially by someone who's so beloved
like night follows day, I think, when it's almost $300 million. Yeah, well, and what's interesting about this is typically when people pass down a wealth, they create a marital trust. Jimmy chose to have a second trustee.
Now, clearly he assumed they would get along. Now, why did he appoint a second trustee? Either he just didn't want his wife to have to worry about all these business issues, or he wanted someone else in the room to monitor things. Either way, she doesn't like it. She would have had to sign off on the marital trust to begin with, right? No, that's part of Jimmy's... And Jimmy had a very... The irony here is he had a very detailed, well-constructed plan for this estate. And it still fell apart because of...
Often the reason they fell apart, which is personalities and emotions. And she just doesn't want somebody else telling her what she can do. And he, Mosenter, for his part, says, I represent what Jimmy would have wanted. And he would have wanted oversight. He wouldn't have wanted her. You ought to be able to get 10%.
not 1%. Well, a lot of these assets are illiquid. That's the big problem. And they're also not income producing. Now, we don't know what the song catalog is. That wasn't listed as an asset in this case. We don't know what kind of income that produces. Although Margaritaville in the previous quarter was throwing off like $14 million a year. So why that wasn't in this projection of $2 million, we don't know. Well, that does seem pretty stingy if you're looking at that.
And so it just appears to be a clash. So what a judge is likely to do is step in here and say, like, okay, you guys can't work it out clearly. We're going to put in a professional trustee, which probably should have happened in the first place. A lot of people disappoint a friend as a co-trustee saying, I trust this guy. I trust this guy. He's not going to steal money.
But oftentimes that creates a personality issue. - But it's the illiquid nature of the assets that are probably the bigger problem here too. You can't sell down some of these things. And that's gotta be frustrating. - And when I talk to a lot of probate attorneys, they say with $100 trillion in wealth being passed down to next generations over the next 25 years, they are seeing a flood of cases
around estate transfers. And again, no matter how well constructed the plan might be, it's always personalities, it's always emotions, and if death and taxes are certain, fights over inheritance is inevitable. It almost always happens, especially when you get numbers, Joe, to your point, like $275 million. I wish I was leaving a private jet in my will.
i don't see i don't see that i have a private jet card he had a warren he had a company called strange bird that invested money on it that invested in aircraft and apparently but he he had a jet i'm sure he probably it looks like it sounds like it looks like you had multiple shares or equity in multiple planes in multiple planes and i don't know how you get that to that number in cars i made enough money to buy miami but i pissed it all away never meant to last never meant to last
And that is Squawk Pod for today. Thanks for listening. Squawk Box is hosted by Joe Kernan, Becky Quick, and Andrew Ross Sorkin. Tune in weekday mornings on CNBC at 6 Eastern, or listen to Squawk Pod anytime you want and get the best of our show right into your ears. We're on X at Squawk CNBC. Reach out anytime. We love to hear from you. Have a great Wednesday. We'll meet you right back here tomorrow. We are clear. Thanks, guys.
Dear Truckin' Awesome, Toyota Tundra's got heart-pounding horsepower. Tacoma is one rugged ride, and the 4Runner is tough as nails. Truck yeah! Find yours at Toyota.com. Toyota, let's go places.